MIM
PYXS icon

Monashee Investment Management’s Pyxis Oncology PYXS Stock Holding History

Monashee Investment Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-442,500
Closed -$1.89M – 124
2024
Q1 		$1.89M Buy
+442,500
New +$1.86M 0.22% 72

Other funds holding PYXS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Monashee Investment Management's PYXS Position: Q2 2024 in Review

Monashee Investment Management sold out of Pyxis Oncology (PYXS) in Q2 2024, closing a stake of 442,500 shares — an estimated $1.89M sold.

Monashee Investment Management first reported a position in PYXS in Q1 2024 and held it in 1 quarter. The position peaked at $1.89M in Q1 2024. 80 funds tracked by Wall St. Rank hold PYXS as of Q2 2024.

  • Monashee Investment Management reported no remaining Pyxis Oncology position as of Q2 2024 after selling out during the quarter.
  • Monashee Investment Management sold 442,500 Pyxis Oncology shares in Q2 2024, an estimated $1.89M.
  • Monashee Investment Management first reported a position in Pyxis Oncology in Q1 2024 and held it in 1 quarter.
  • Monashee Investment Management's Pyxis Oncology position peaked at $1.89M in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2024.

Based on Monashee Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.